Envestnet Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.51M | Buy |
|
|||||
2025
Q1 | $2.37M | Buy |
|
|||||
2024
Q4 | $1.96M | Sell |
|
|||||
2024
Q3 | $1.83M | Buy |
|
|||||
2024
Q2 | $1.75M | Buy |
|
|||||
2024
Q1 | $1.95M | Sell |
|
|||||
2023
Q4 | $4.73M | Sell |
|
|||||
2023
Q3 | $3.58M | Buy |
|
|||||
2023
Q2 | $2.22M | Buy |
|
|||||
2023
Q1 | $1.22M | Buy |
|
|||||
2022
Q4 | $867K | Sell |
|
|||||
2022
Q3 | $960K | Sell |
|
|||||
2022
Q2 | $891K | Sell |
|
|||||
2022
Q1 | $1.72M | Sell |
|
|||||
2021
Q4 | $1.81M | Sell |
|
|||||
2021
Q3 | $1.7M | Sell |
|
|||||
2021
Q2 | $2.56M | Buy |
|
|||||
2021
Q1 | $2.62M | Buy |
|
|||||
2020
Q4 | $1.17M | Buy |
|
|||||
2020
Q3 | $769K | Buy |
|
|||||
2020
Q2 | $774K | Buy |
|
|||||
2020
Q1 | $669K | Buy |
|
|||||
2019
Q4 | $579K | Buy |
|
|||||
2019
Q3 | $383K | Buy |
|
|||||
2019
Q1 | – | Sell |
|
|||||
2018
Q4 | $168K | Buy |
|
|||||
2018
Q3 | – | Sell |
|
|||||
2018
Q2 | $9K | Buy |
|
|||||
2018
Q1 | $12K | Buy |
|
|||||
2017
Q4 | $10K | Sell |
|
|||||
2017
Q3 | $17K | Sell |
|
|||||
2017
Q2 | $61K | Sell |
|
|||||
2017
Q1 | $113K | Buy |
|
|||||
2016
Q4 | $77K | Sell |
|
|||||
2016
Q3 | $87K | Sell |
|
|||||
2016
Q2 | $121K | Buy |
|
|||||
2016
Q1 | $91K | Buy |
|
|||||
2015
Q4 | $73K | Buy |
|
|||||
2015
Q3 | $67K | Buy |
|
|||||
2014
Q4 | – | Sell |
|
|||||
2014
Q3 | $1K | Hold |
|
|||||
2014
Q2 | $1K | Hold |
|
|||||
2014
Q1 | $1K | Buy |
|